A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has successfully developed a neutralizing monoclonal antibody, 6H2, which targets a harmful protein known to exacerbate damage caused by ischemic stroke.
New monoclonal antibody for treating cerebral ischemia injury
